Heron Therapeutics Announces Upcoming Third Quarter Financial Report
Heron Therapeutics, Inc. (NASDAQ: HRTX), a leading commercial-stage biotechnology company, is gearing up to present its third quarter financial results. The company has confirmed that a live conference call and webcast will take place on an upcoming Tuesday morning. This event serves as an excellent opportunity for investors and stakeholders to gain insights into the firm’s financial health and recent advancements.
Details of the Financial Call
The scheduled conference call will begin promptly at 8:00 a.m. ET. Participants interested in joining are advised to register through a dedicated link provided by the company. Heron encourages all attendees to dial in at least fifteen minutes early to ensure a prompt start.
Accessing the Webcast
Alongside the phone conference, the event will also be available via webcast. Individuals can easily access this feature through the Investor Relations section of Heron's official website. Following the live event, an archived version of the teleconference will be accessible for a period of 60 days, allowing a broader audience to catch up on the discussions.
About Heron Therapeutics
Heron Therapeutics is at the forefront of biotechnology, focusing on creating innovative treatments that enhance patient care. Their commitment to utilizing advanced scientific methods and patented technologies has led to a diverse portfolio of therapeutic products aimed at elevating standards of care, particularly for patients undergoing acute and oncological treatment.
Innovations and Achievements
Heron's dedicated research efforts have resulted in several advancements in drug discovery and development. The company continually seeks to push the boundaries of medical treatment through its innovative strategies, ensuring that patients receive the best available care. These initiatives are vital for maintaining competitive positioning in the biotechnology sector.
Investor Relations and Contact Information
For further inquiries, Ira Duarte, the Executive Vice President and Chief Financial Officer at Heron Therapeutics, is the primary contact person. Interested parties can reach out via email or phone for additional information regarding the conference call or company operations.
Contact Details
Name: Ira Duarte
Role: Executive Vice President, Chief Financial Officer
Email: iduarte@herontx.com
Phone: 858-251-4400
Frequently Asked Questions
What is the purpose of the conference call?
The conference call aims to report the financial results for the third quarter and discuss recent business highlights of Heron Therapeutics.
How can I participate in the conference call?
Participants can join by registering through the provided link, which will give them dial-in information. It’s recommended to call in early.
Will the conference be available for later viewing?
Yes, an archive of the teleconference will be available on Heron’s website for 60 days following the event.
What is Heron Therapeutics focused on?
Heron Therapeutics concentrates on developing and commercializing therapeutic innovations aimed at improving medical care for patients.
Who can I contact for more information?
For further details, you can contact Ira Duarte, Chief Financial Officer, at the provided email or phone number.
